Abstract
INTRODUCTION. Chronic pain represents an important interdisciplinary problem. A distinction should be made between primary and secondary chronic pain, which can be subdivided into oncologic and non-oncologic pain. The diagnosis of chronic pain is based on the use of assessment scales. Therapy of patients suffering from chronic pain should be based on clinical guidelines. The choice of therapy for chronic pain syndrome should be etermined by the intensity of pain and the pathogenetic characterization of pain. Opioid therapy is one of the main ethods of treatment of chronic pain in palliative care of oncologic and non-oncologic patients. CONCLUSION. Tapentadol (Palexia retard) is an effective analgesic in the therapy of chronic pain syndrome of moderate to high intensity in patients suffering from oncologic and non-oncologic pain. KEYWORDS: chronic pain, opioids, Tapentadol
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
